Browse by author
Lookup NU author(s): Dr Karthik Balasubramaniam,
Dr Girish Viswanathan,
Professor Azfar Zaman
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Platelets play a central role in atherothrombotic events. We investigated the effect of a novel platelet-lowering agent, rafigrelide, on thrombus formation and characteristics. In this phase 1, open-label, non-randomised, single-sequence, crossover study, healthy male volunteers received rafigrelide for 14 days (Period 1). Following a >= 6-week washout period, they then received rafigrelide + acetylsalicylic acid (ASA) for 14 days (Period 2). Thrombus formation was assessed ex vivo using the Badimon perfusion chamber, and thrombus characteristics were assessed using thromboelastography. A total of 15 volunteers were enrolled in the study and were assigned to Panel A or Panel B, which had different schedules of assessments. In Panel A, after treatment with rafigrelide alone (Period 1), mean (+/- standard deviation) platelet count was reduced from 283 (+/- 17) x 10(9)/I at Day 1, to 125 (+/- 47) x 10(9)/I at Day 14 (n=6) and thrombus area reduced under high and low shear conditions. Reductions in thrombus area under high shear conditions correlated with reductions in platelet count (r(2)=0.11, p=0.022; n=12). Rafigrelide treatment prolonged clot formation time and reduced clot strength. The addition of ASA to rafigrelide (Period 2) had no additional effect on platelet count or thrombus area under high or low shear conditions. Similar results were seen in Panel B for all parameters. The most common adverse events (>= 3 participants per period) were thrombocytopenia and headache. While confirming the platelet-lowering effects of rafigrelide, this early phase study also indicates that rafigrelide has antithrombotic properties under both high and low shear conditions.
Author(s): Balasubramaniam K, Viswanathan G, Dragone J, Grose-Hodge R, Martin P, Troy S, Preston P, Zaman AG
Publication type: Article
Publication status: Published
Journal: Thrombosis and Haemostasis
Print publication date: 20/02/2014
ISSN (print): 0340-6245
Publisher: Schattauer GmbH
Altmetrics provided by Altmetric